Alnylam Pharmace. buy Bank of America Co.
Start price
04.09.24
/
50%
€228.50
Target price
04.09.25
€277.62
Performance (%)
69.02%
End price
05.09.25
€386.20
Summary
This prediction ended on 05.09.25 with a price of €386.20. With a performance of 69.02% the BUY prediction by Bank_of_America_Co_ was a big success. Bank_of_America_Co_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Bank_of_America_Co_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -7.577% | -7.577% | 1.524% |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Bank of America Co. from $295.00 to $307.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€270.80
11.07.25
11.07.25
€307.48
11.07.26
11.07.26
-4.06%
12.02.26
12.02.26
Stopped prediction by Bank_of_America_Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€305.80
12.01.26
12.01.26
€453.72
12.01.27
12.01.27
-15.04%
12.02.26
12.02.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€386.50
17.09.25
17.09.25
€438.62
17.09.26
17.09.26
-32.78%
12.02.26
12.02.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€259.80
14.10.24
14.10.24
€287.94
14.10.25
14.10.25
54.66%
15.10.25
15.10.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€222.50
25.06.24
25.06.24
€275.35
25.06.25
25.06.25
24.90%
26.06.25
26.06.25